✦ LIBER ✦

Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers

✍ Scribed by R. M. Antonijoan; M. J. Barbanoj; J. A. Cordero; C. Peraire; R. Obach; J. Vallès; R. CheZérif-Cheikh; M.-L. Torres; F. Bismuth; M. Montes

Book ID: 111769095
Publisher: Pharmaceutical Press
Year: 2004
Tongue: English
Weight: 259 KB
Volume: 56
Category: Article
ISSN: 2042-7158
DOI: 10.1211/0022357023123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of the new long-acting formulat

Efficacy of the new long-acting formulation of lanreotide (Lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly

✍ Lombardi, G.; Minuto, F.; Tamburrano, G.; Ambrosio, M. R.; Arnaldi, G.; Arosio, 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 149 KB

Single dose pharmacokinetics of HEPP, a

Single dose pharmacokinetics of HEPP, a new anticonvulsant in normal healthy volunteers

✍ Dinora F. González-Esquivel; Francisco Rubio-Donnadieu; Guillermo Carvajal S.; H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

The pharmacokinetics and the dose proportionality of a new anticonvulsant compound, HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) was studied in healthy male volunteers as part of the pharmacological evaluation for new drugs. Study was performed administering doses of 250, 375, 500 and 625 mg of

Single and multiple dose pharmacokinetic

Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers

✍ L. Martinez; J. Sanchez; R. Roser; J. Garcia-Barbal; R. Sagarra; A. Bartlett 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 495 KB

Pharmacokinetics and tolerance of a new

Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose

✍ M. G. Jannuzzo; M. Mandelli; M. Strolin Benedetti; E. Moro; M. Carnovali; R. Vai 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 327 KB

Effects of a slow-release formulation of

Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas

✍ A. Gancel; P. Vuillermel; A. Legrand; F. Catus; F. Thomas; Professor J. M. Kuhn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers

✍ M. Lefebvre; Y. Lacasse; J. Spénard; D. Geadah; R. Moisan; D. Gossard; H. Landri 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

Diltiazem is a calcium antagonist used in angina pectoris and hypertension. There is little information concerning the slow-release (SR) formulation in the literature. The pharmacokinetics of diltiazem SR (120 mg) have been assessed over a 36 h period in healthy volunteers after single-(SD) and mult